EMA has endorsed a joint COVID-19 statement published by the International Coalition of Medicines Regulatory Authorities (ICMRA) committing to a strengthening of global collaboration in the fight against coronavirus disease.
The COVID-19 pandemic affects the whole world and the best way to fight it is through globally concerted actions,’ said Guido Rasi, Chair of ICMRA and EMA’s Executive Director. ‘Our collaboration as regulators is crucial to increase the efficiency of regulatory processes and decision-making that will facilitate rapid development, approval and global roll-out of safe and efficacious medicines against COVID-19...
Full text at GMPnews.Net